A. Ferrant

439 total citations
6 papers, 306 citations indexed

About

A. Ferrant is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, A. Ferrant has authored 6 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Hematology, 2 papers in Public Health, Environmental and Occupational Health and 1 paper in Surgery. Recurrent topics in A. Ferrant's work include Acute Myeloid Leukemia Research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper). A. Ferrant is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper). A. Ferrant collaborates with scholars based in Belgium, Italy and Netherlands. A. Ferrant's co-authors include Y Najean, S Chinn, Giovanni Barosi, Thomas C. Pearson, David Guthrie, J. A. Simpson, S. M. Lewis, Guy Cornu, Jl. Michaux and Jean‐Luc Gala and has published in prestigious journals such as Blood, British Journal of Haematology and Annals of Hematology.

In The Last Decade

A. Ferrant

5 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Ferrant Belgium	3	91	75	65	57	49	6	306
Giampiera Bertolino Italy	14	93 1.0×	223 3.0×	73 1.1×	56 1.0×	31 0.6×	36	407
M Samama France	10	46 0.5×	211 2.8×	40 0.6×	24 0.4×	19 0.4×	43	387
Der‐Cherng Tarng Taiwan	11	72 0.8×	181 2.4×	47 0.7×	26 0.5×	54 1.1×	12	531
Kai Uwe Eckardt Germany	7	32 0.4×	70 0.9×	34 0.5×	52 0.9×	19 0.4×	9	360
Patrizia Bernich Italy	10	116 1.3×	159 2.1×	21 0.3×	79 1.4×	40 0.8×	24	510
Gianluca Usala Italy	5	124 1.4×	115 1.5×	53 0.8×	129 2.3×	47 1.0×	5	502
Kirti Kain United Kingdom	12	50 0.5×	121 1.6×	42 0.6×	76 1.3×	32 0.7×	19	437
Filippo Mangione Italy	9	30 0.3×	61 0.8×	33 0.5×	28 0.5×	22 0.4×	16	269
J L Barron United Kingdom	13	26 0.3×	27 0.4×	46 0.7×	53 0.9×	95 1.9×	29	494
S Rekola Sweden	8	39 0.4×	52 0.7×	26 0.4×	39 0.7×	15 0.3×	9	302

Countries citing papers authored by A. Ferrant

Since Specialization

Citations

This map shows the geographic impact of A. Ferrant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Ferrant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Ferrant more than expected).

Fields of papers citing papers by A. Ferrant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Ferrant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Ferrant. The network helps show where A. Ferrant may publish in the future.

Co-authorship network of co-authors of A. Ferrant

This figure shows the co-authorship network connecting the top 25 collaborators of A. Ferrant. A scholar is included among the top collaborators of A. Ferrant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Ferrant. A. Ferrant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Witte, T de, Stefan Suciu, Michel Delforge, et al.. (2001). Cytogenetic risk group and cytogenetic response predict outcome of patients with poor-risk mds and secondary aml treated with intensive chemotherapy and stem cell transplantation in a joint study (CRIANT) of the EORTC, EBMT, SAKK, HOVON and GIMEMA leukemia groups. Blood. 98(11). 1 indexed citations

2.

Pearson, Thomas C., David Guthrie, J. A. Simpson, et al.. (1995). Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology. British Journal of Haematology. 89(4). 748–756. 251 indexed citations

3.

Gala, Jean‐Luc, C. Vermylen, Guy Cornu, et al.. (1994). High expression of bcl-2 is the rule in acute lymphoblastic leukemia, except in Burkitt subtype at presentation, and is not correlated with the prognosis. Annals of Hematology. 69(1). 17–24. 49 indexed citations

4.

Gratwohl, Aloïs, J. Hermans, Anja van Biezen, et al.. (1993). Splenic Irradiation before Bone Marrow Transplantation for Chronic Myeloid Leukemia: Update of a Prospective Randomized Study. Leukemia & lymphoma. 11(sup1). 227–231. 3 indexed citations

5.

Clarysse, Albert, et al.. (1978). Domperidone (R 33812) in the prophylactic treatment of chemotherapy-induced emesis. A multicentre evaluation.. PubMed. 28(4). 686–8. 2 indexed citations

6.

Michaux, Jean‐Louis, et al.. (1973). Le Probleme De La Fievre Dans Les Leucemies Et Les Hematosarcomes Traites Et Non Traites. Acta Clinica Belgica. 28(2). 129–135.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact